10x Genomics (TXG) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free TXG Stock Alerts $25.68 -0.71 (-2.69%) (As of 12:10 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability 10x Genomics Short Interest DataCurrent Short Volume10,260,000 sharesPrevious Short Volume8,870,000 sharesChange Vs. Previous Month+15.67%Dollar Volume Sold Short$300.41 millionShort Interest Ratio / Days to Cover6.4Last Record DateApril 30, 2024Outstanding Shares119,170,000 sharesPercentage of Shares Shorted8.61%Today's Trading Volume399,012 sharesAverage Trading Volume1,558,210 sharesToday's Volume Vs. Average26% Short Selling 10x Genomics ? Sign up to receive the latest short interest report for 10x Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTXG Short Interest Over TimeTXG Days to Cover Over TimeTXG Percentage of Float Shorted Over Time Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. 10x Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,260,000 shares $300.41 million +15.7%N/A6.4 $29.28 4/15/20248,870,000 shares $291.47 million +4.1%N/A6.3 $32.86 3/31/20248,520,000 shares $319.76 million -0.7%N/A6.1 $37.53 3/15/20248,580,000 shares $311.71 million +24.5%N/A6.3 $36.33 2/29/20246,890,000 shares $321.35 million +7.3%N/A5.2 $46.64 2/15/20246,420,000 shares $308.61 million -3.6%N/A5.2 $48.07 Get the Latest News and Ratings for TXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 10x Genomics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,660,000 shares $277.52 million +16.4%N/A5.7 $41.67 1/15/20245,720,000 shares $268.78 million +22.8%N/A4.8 $46.99 12/31/20234,660,000 shares $260.77 million -15.4%N/A4.5 $55.96 12/15/20235,510,000 shares $294.62 million +6.2%N/A5.7 $53.47 11/30/20235,190,000 shares $225.87 million -8.6%N/A5.4 $43.52 11/15/20235,680,000 shares $229.53 million -15.7%N/A5.8 $40.41 10/31/20236,740,000 shares $237.79 million +0.6%N/A7 $35.28 10/15/20236,700,000 shares $258.02 million +16.7%N/A7.2 $38.51 9/30/20235,740,000 shares $236.78 million +13.7%N/A6.1 $41.25 9/15/20235,050,000 shares $251.14 million +5.7%N/A5.4 $49.73 8/31/20234,780,000 shares $247.84 million -1.0%N/A5.2 $51.85 8/15/20234,830,000 shares $235.37 million +1.5%N/A5.1 $48.73 7/31/20234,760,000 shares $299.78 million -5.6%N/A5 $62.98 7/15/20235,040,000 shares $292.82 million -5.6%5.9%5.4 $58.10 6/30/20235,340,000 shares $298.19 million +3.5%6.3%5.9 $55.84 6/15/20235,160,000 shares $303.00 million -3.9%6.1%5.7 $58.72 5/31/20235,370,000 shares $281.71 million -2.2%6.3%5.9 $52.46 5/15/20235,490,000 shares $295.42 million -8.0%N/A6.2 $53.81 4/30/20235,970,000 shares $313.01 million -6.6%N/A6.5 $52.43 4/15/20236,390,000 shares $345.25 million -3.2%N/A7.1 $54.03 3/31/20236,600,000 shares $368.21 million +2.5%N/A6.5 $55.79 3/15/20236,440,000 shares $312.86 million +4.4%N/A6.2 $48.58 2/28/20236,170,000 shares $293.20 million +5.8%N/A5.5 $47.52 2/15/20235,830,000 shares $269.75 million -4.6%N/A5.1 $46.27 1/31/20236,110,000 shares $286.13 million -1.5%7.1%5 $46.83 1/15/20236,200,000 shares $267.96 million -16.9%7.2%4.6 $43.22 12/30/20227,460,000 shares $271.84 million -13.5%8.7%5.7 $36.44 12/15/20228,620,000 shares $308.42 million -3.3%10.1%6.7 $35.78 11/30/20228,910,000 shares $344.46 million +4.2%10.4%7 $38.66 11/15/20228,550,000 shares $346.28 million +50.3%10.0%6.9 $40.50 10/31/20225,690,000 shares $154.65 million +15.7%6.7%4.6 $27.18 10/15/20224,920,000 shares $125.85 million -6.8%5.8%4.3 $25.58 9/30/20225,280,000 shares $150.37 million +1.3%6.2%4 $28.48 9/15/20225,210,000 shares $174.48 million +9.9%6.1%3.7 $33.49The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development TXG Short Interest - Frequently Asked Questions What is 10x Genomics' current short interest? Short interest is the volume of 10x Genomics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 10,260,000 shares of TXG short. Learn More on 10x Genomics' current short interest. What is a good short interest ratio for 10x Genomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXG shares currently have a short interest ratio of 6.0. Learn More on 10x Genomics's short interest ratio. Is 10x Genomics' short interest increasing or decreasing? 10x Genomics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 10,260,000 shares, an increase of 15.7% from the previous total of 8,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 10x Genomics' short interest compare to its competitors? Here is how the short interest of companies compare to 10x Genomics: Olink Holding AB (publ) (1.99%), Cytek Biosciences, Inc. (6.59%), Bio-Rad Laboratories, Inc. (3.73%), IDEAYA Biosciences, Inc. (16.17%), Amedisys, Inc. (7.25%), Sotera Health (8.30%), iRhythm Technologies, Inc. (9.58%), SpringWorks Therapeutics, Inc. (13.51%), Xenon Pharmaceuticals Inc. (3.70%), Summit Therapeutics Inc. (28.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short 10x Genomics stock? Short selling TXG is an investing strategy that aims to generate trading profit from 10x Genomics as its price is falling. TXG shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 10x Genomics? A short squeeze for 10x Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TXG, which in turn drives the price of the stock up even further. How often is 10x Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXG, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: OLK Short Squeeze CTKB Short Squeeze BIO Short Squeeze IDYA Short Squeeze AMED Short Squeeze SHC Short Squeeze IRTC Short Squeeze SWTX Short Squeeze XENE Short Squeeze SMMT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TXG) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity